| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 08/26/2004 | DE19839013B4 Verfahren zur Hestellung von Guanin Process for the operations department of guanine |
| 08/25/2004 | EP1449843A1 Intermediates for the preparation of carbamoyl tetrahydropyridine derivatives |
| 08/25/2004 | EP1366048B1 Pyrazolopyridine derivatives |
| 08/25/2004 | CN1163502C Novel A1 adenosine receptor incitant |
| 08/24/2004 | US6780865 Substituted chiral xanthine compound, stability in adverse chemical and dynamic biologic environments |
| 08/24/2004 | US6780529 Heterocyclic compound and light-emitting device using same |
| 08/24/2004 | CA2065051C Improved use of .beta.2 bronchodilator drugs |
| 08/19/2004 | WO2004069847A1 Nucleoside analogues with apoptosis-inducing characteristics for treating diseases caused by rapidly proliferating cells |
| 08/19/2004 | WO2004069823A1 Inhibitors of histone deacetylase |
| 08/19/2004 | WO2004069394A2 Synthetic method for direct arylation of heterocyclic arenes |
| 08/19/2004 | WO2004069185A2 Partial and full agonists of a1 adenosine receptors |
| 08/19/2004 | WO2004069168A2 Novel antiherpes drug combinations |
| 08/19/2004 | WO2004029579A3 Fluorescent labeling reagents with multiple donors and acceptors |
| 08/19/2004 | US20040162422 adenosine derivatives having an acetylene group in the 4' position, which are adenosine A1 agonists; treating ischaemic heart disease, peripheral vascular disease or stroke or patient suffering pain, a CNS disorder, sleep apnoea or emesis |
| 08/19/2004 | US20040162282 Substituted piperazines |
| 08/19/2004 | CA2515068A1 Partial and full agonists of a1 adenosine receptors |
| 08/19/2004 | CA2514334A1 Novel antiherpes drug combinations |
| 08/18/2004 | EP1447407A1 Adenosine derivatives |
| 08/18/2004 | EP1446117A2 Treatment of acute myeloid leukemia with indolinone compounds |
| 08/18/2004 | EP1257552B1 Xanthine derivatives, intermediates and use for treating osteoporosis |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157864 Compositions and methods for inducing osteogenesis |
| 08/12/2004 | US20040157829 useful in the treatment of central or peripheral nervous system disorders(e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, epilepsy, hearing and vision loss, Alzheimer's disease, etc.) and as neuroprotective agent |
| 08/11/2004 | EP1444233A2 A 2b? adenosine receptor antagonists |
| 08/11/2004 | EP1443932A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 08/11/2004 | CN1161357C Prepn process of 2,6-dichloropurine |
| 08/11/2004 | CN1161356C Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' |
| 08/11/2004 | CN1161343C Cholopyrimidine intermediate |
| 08/10/2004 | US6774130 Treating chronic inflammatory disease, chronic intestinal inflammation, arthritis, psoriasis, asthma and autoimmune disorders; th1 cell-mediated disorders; for example, 1,2,3,6-tetrahydro-7h-purine-2,6-dione derivatives |
| 08/05/2004 | WO2004065386A1 2,6-dihalogeno-8-substituent-purine compound and process for producing the same |
| 08/05/2004 | CA2514151A1 2,6-dihalogeno-8-substituent-purine compound and process for producing the same |
| 08/04/2004 | CN1518550A Imidazo [1,2-A] pyridine derivatives for prophylaxis and treatment of herpes viral infections |
| 08/04/2004 | CN1518534A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 08/04/2004 | CN1518450A Use of adenosine analogues for treatment of insulin resisttance syndrome and diabetes |
| 08/04/2004 | CN1160356C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 08/04/2004 | CN1160355C Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 08/04/2004 | CN1160354C Process for synthesis of chloropurine intermediates |
| 08/03/2004 | US6770651 A2B adenosine receptor antagonists |
| 08/03/2004 | US6770267 Methods of treating periodontal disease |
| 07/29/2004 | WO2004063169A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | WO2004063159A1 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
| 07/29/2004 | WO2004063151A2 Novel tyrosine kinase inhibitors |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004014913A3 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 07/29/2004 | US20040147743 Obtaining higher purity alcohol product; acid hydrolysis of diether followed by aldehyde reduction without intermediate isolation; such as high yield valomaciclovir stearate |
| 07/29/2004 | US20040147548 2-NH-heteroarylimidazoles with antibacterial activity |
| 07/29/2004 | US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 07/29/2004 | CA2513436A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/28/2004 | EP1441224A2 Enzyme inhibition immunoassay |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440072A2 Purine analogs having hsp90-inhibiting activity |
| 07/28/2004 | CN1515673A Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative |
| 07/28/2004 | CN1515572A Carbocyclic nucleoside semi-sulfate and its application for curing viral infection |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1159314C Thiazolidinedione derivs. as antidiabetic agents |
| 07/27/2004 | US6767906 Inhibit p34cdc2/cyclin bcdc13 kinase and protein tyrosine kinase pp60c-src and can be used for treatment of hyperproliferative diseases, for example chemotherapy of tumours or osteoporosis. |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142451 one linker, a biomolecule coupled to the linker, and cyclohexane derivatives |
| 07/22/2004 | US20040142436 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-(2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | CA2216634C Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 07/15/2004 | WO2004058791A2 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | US20040138272 Central nervous system disorders; anticancer agents; antiproliferative agents |
| 07/15/2004 | US20040138215 Angiotensin conveerting enzyme inhibitor; antiarthritic agents; obsity;antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138214 Antidiabetic agents; dietetics; antiarthritic agents; osteoporosis; angiotensin converting enzyme inhibitor |
| 07/15/2004 | US20040138212 Disubstituted 1,7-guanines |
| 07/14/2004 | EP1436295A2 Crystalline forms of valacyclovir hydrochloride |
| 07/14/2004 | EP1435974A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 07/14/2004 | CN1512992A Novel adenine derivatives |
| 07/13/2004 | US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6761767 Production method of famciclovir and production and crystallization method of intermediate therefor |
| 07/08/2004 | WO2004029578A3 Energy transfer dyes, terminators and use thereof |
| 07/08/2004 | WO2003024965A3 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| 07/08/2004 | US20040132981 modified ligands that bind irreversibly to their cognate receptors; assay for investigating protein function and as drugs for more effectively inhibiting or stimulating cognate receptor function |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132749 e.g., R)-9-[2-(Stearoyloxymethyl)- and (R)-9-[2-(Myristoyloxymethyl)-4-(L-valyloxy)butyl]guanine; treatment or prophylaxis of viral infections such as those caused by Varicella zoster, Herpes, Epstein-Barr SIV, HIV-1 or HIV-2. |
| 07/08/2004 | US20040132748 Novel adenne derivatives |
| 07/08/2004 | US20040132747 Novel heteroaryl derivatives and their use as medicaments |
| 07/08/2004 | US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/01/2004 | WO2004055017A1 2-nitropurine compound and process for producing the same |
| 07/01/2004 | WO2004055002A1 Carbazole derivatives and their use as npy-5 antagonists |
| 07/01/2004 | WO2004016612A3 New purine derivatives |
| 07/01/2004 | CA2510683A1 Carbazole derivatives and their use as npy-5 antagonists |
| 06/30/2004 | EP1432734A1 Cytokine receptor |
| 06/30/2004 | EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 06/30/2004 | EP1113802B1 Antiviral combinations of lamivudine and adefovir |
| 06/30/2004 | CN1155608C Propargyl phenyl ether A2A receptor agonists |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756367 Useful in the treatment of any state with increased endogenous level of corticotropin releasing hormone(crf) or hpa (hypothalamic pituitary axis) is disregulated or diseases induced by crf, including inflammatory disorders, anxiety etc |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/24/2004 | WO2004052892A1 Anhydrous crystalline form of valacyclovir hydrochloride |
| 06/24/2004 | WO2004052879A1 Thiophenederivatives for the treatment of flavivirus infections |